oleic acid has been researched along with atorvastatin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Adeli, K; Dulay, D; Macri, J; Mohammadi, A; Newton, R; Romain, T | 1 |
| Adzet, T; Alegret, M; Cabrero, A; Laguna, JC; Sánchez, RM; Vázquez, M | 1 |
| Funatsu, T; Goto, M; Ida, M; Kakuta, H; Miyata, K; Nishijima, S; Suzuki, M; Tanaka, H; Yasuda, S | 1 |
| Botma, GJ; Jansen, H; van Deursen, D; van Hoek, M; Verhoeven, AJ; Vieira, D | 1 |
| Ahmed, OA; Al-Sawahli, MM; Hashem, FM; Nasr, M | 1 |
| Diril, M; Karasulu, HY; Türkyılmaz, GY | 1 |
| Elhuoni, MA; Ghoneim, AM; Ishak, RAH; Shaker, DS | 1 |
8 other study(ies) available for oleic acid and atorvastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Topics: Albumins; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Cell Membrane Permeability; Cholesterol; Cholesterol Esters; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Fluid; Leupeptins; Multienzyme Complexes; Oleic Acid; Proteasome Endopeptidase Complex; Pyrroles; Tumor Cells, Cultured | 1998 |
Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes.
Topics: Acyl-CoA Dehydrogenase; Animals; Atorvastatin; Bezafibrate; Carnitine O-Palmitoyltransferase; Carrier Proteins; Cell Line; Cholesterol; Chromans; Down-Regulation; Fatty Acid Desaturases; Heptanoic Acids; Hypoglycemic Agents; Ion Channels; Ligands; Membrane Transport Proteins; Mice; Mitochondrial Proteins; Muscles; Oleic Acid; Peroxisome Proliferators; Proteins; Pyrimidines; Pyrroles; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Triazenes; Troglitazone; Uncoupling Protein 2; Uncoupling Protein 3 | 2000 |
Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Coenzyme A Ligases; Dietary Sucrose; Disease Models, Animal; Down-Regulation; Fatty Acids, Nonesterified; Heptanoic Acids; Hypertriglyceridemia; Lipase; Lipoproteins, VLDL; Liver; Male; Oleic Acid; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triglycerides; Tritium | 2002 |
Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression.
Topics: Anticholesteremic Agents; Atorvastatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholesterol; DNA-Binding Proteins; Fatty Acids, Unsaturated; Gene Expression Regulation, Enzymologic; Heptanoic Acids; Homeostasis; Humans; Lipase; Liver Neoplasms; Oleic Acid; Promoter Regions, Genetic; Pyrroles; Sterol Regulatory Element Binding Protein 2; Transcription Factors | 2005 |
Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability.
Topics: Administration, Oral; Animals; Atorvastatin; Biological Availability; Chemistry, Pharmaceutical; Drug Carriers; Electric Conductivity; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Microscopy, Electron, Transmission; Models, Theoretical; Nanomedicine; Nanoparticles; Oleic Acid; Particle Size; Polyethylene Glycols; Polysorbates; Rats, Wistar; Solubility; Technology, Pharmaceutical; Ultrasonics | 2015 |
Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System Containing Atorvastatin Calcium.
Topics: Atorvastatin; Caco-2 Cells; Drug Compounding; Drug Delivery Systems; Emulsions; Ethanol; Hexoses; Humans; Lipids; Oleic Acid; Particle Size; Polysorbates; Solubility; Surface Properties; Surface-Active Agents; Tumor Cells, Cultured | 2019 |
Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation.
Topics: Administration, Cutaneous; Animals; Atorvastatin; Biological Availability; Drug Liberation; Emulsions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nanoparticles; Oleic Acid; Polyethylene Glycols; Polysorbates; Rats, Wistar; Skin; Skin Absorption; Solubility | 2020 |